Table 1.
LncRNAs related to sepsis.
| LncRNAs | Expression in sepsis | Target gene | Model |
|---|---|---|---|
| MALAT1 | Up | miR-125b | Mice |
| NEAT1 | Up | miR-204 | Humans in vitro |
| NEAT1 | Up | Humans | |
| NEAT1 | Up | Mice | |
| NEAT1 | Up | – | Humans |
| Lnc-ANRIL | Up | – | Humans |
| Lnc-ANRIL/miR-125a axis | Up | Humans | |
| HOTAIR | Up | Rats in vitro | |
| HOTAIR | – | Rats | |
| LncRNA H19 | Down | Humans in vitro | |
| LncRNA ITSN1-2 | Up | Humans | |
| HULC | Up | – | Mice in vitro |
| UCA1 | |||
| TUG1 | Down | Humans in vitro | |
| TapSAKI | Up | Rats in vitro | |
| HOTAIR | Up | – | Mice |
| MALAT1 | Up | – | Mice in vitro |
| MALAT1 and EZH2 | Up | – | Rats in vitro |
Lnc/LncRNA long noncoding RNA, miR microRNA, MALAT1 metastasis-associated lung adenocarcinoma transcript 1, NEAT1 nuclear paraspeckle assembly transcript 1, ANRIL antisense noncoding RNA in the INK4 locus, HOTAIR HOX transcript antisense RNA, ITSN1-2 RNA intersectin-2, HULC highly upregulated in liver cancer, UCA1 urothelial carcinoma-associated 1, TUG1 taurine upregulated gene 1, TapSAKI transcript predicting survival in AKI, EZH2 enhancer of zeste homolog 2.